======= PI16 ======= == Gene Information == * **Official Symbol**: PI16 * **Official Name**: peptidase inhibitor 16 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=221476|221476]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q6UXB8|Q6UXB8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PI16&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PI16|Open PubMed]] * **OMIM**: N/A == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May inhibit cardiomyocyte growth. {ECO:0000250|UniProtKB:Q9ET66}. |CAP| |negative regulation of cell growth involved in cardiac muscle cell development| |peptidase inhibitor activity| |negative regulation of cardiac muscle cell differentiation| |regulation of cell growth involved in cardiac muscle cell development| |negative regulation of cardiocyte differentiation| |negative regulation of heart growth| |negative regulation of cardiac muscle tissue growth| |negative regulation of cardiac muscle hypertrophy| |negative regulation of muscle hypertrophy| |negative regulation of organ growth| |negative regulation of cardiac muscle tissue development| |regulation of cardiac muscle cell differentiation| |negative regulation of striated muscle cell differentiation| |negative regulation of striated muscle tissue development| |negative regulation of muscle organ development| |regulation of cardiocyte differentiation| |negative regulation of muscle tissue development| |negative regulation of muscle cell differentiation| |regulation of cardiac muscle hypertrophy| |regulation of cardiac muscle tissue growth| |regulation of muscle hypertrophy| |regulation of heart growth| |regulation of cardiac muscle tissue development| |regulation of muscle adaptation| |regulation of organ growth| |regulation of striated muscle cell differentiation| |negative regulation of developmental growth| |regulation of striated muscle tissue development| |regulation of muscle tissue development| |regulation of muscle organ development| |regulation of muscle cell differentiation| |negative regulation of cell growth| |regulation of muscle system process| |negative regulation of growth| |negative regulation of peptidase activity| |regulation of developmental growth| |negative regulation of cell development| |negative regulation of proteolysis| |regulation of cell growth| |regulation of peptidase activity| |negative regulation of hydrolase activity| |regulation of system process| |regulation of growth| |negative regulation of cell differentiation| |regulation of proteolysis| |negative regulation of catalytic activity| |regulation of cell development| |negative regulation of developmental process| |negative regulation of cellular protein metabolic process| |negative regulation of protein metabolic process| |negative regulation of molecular function| |negative regulation of multicellular organismal process| |regulation of hydrolase activity| |extracellular space| |regulation of cell differentiation| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp443|SNS-032 15μM R08 exp443]]|-2.2| |[[:results:exp99|NFN1 0.4μM R03 exp99]]|-1.75| |[[:results:exp306|Rapamycin 2μM R07 exp306]]|2.03| |[[:results:exp320|ABT-702 5μM plus CoCl2 18μM R07 exp320]]|2.1| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5618 * **Expression level (log2 read counts)**: -0.09 {{:chemogenomics:nalm6 dist.png?nolink |}}